Skip to main content

Table 1 Demographics and clinical characteristics of patients (n = 40)

From: Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease

Characteristics

CMVD (n = 20)

OCAD (n = 20)

Age (years)a

48.45 ± 12.7

58.45 ± 12.7

Females, n (%)

12 (60)

12 (60)

Smokers, n (%)

8 (40)

12 (60)

Alcoholic, n (%)

6 (30)

12 (60)

Hypertensive, n (%)

9 (45)

17 (85)

Diabetic, n (%)

3 (15)

13 (65)

Chest pain, n (%)

10 (50)

8 (40)

Chest tightness, n (%)

9 (45)

1 (5)

Difficulty in breathing, n (%)

1 (5)

7 (35)

NYHA (Class I), n (%)

16 (80)

4 (20)

NYHA (Class II), n (%)

4 (20)

8 (40)

NYHA (Class III), n (%)

0 (0)

6 (30)

NYHA (Class IV), n (%)

0 (0)

2 (10)

Systolic blood pressure (mmHg)a

131.5 ± 20.0

141.7 ± 21.0

Diastolic blood pressure (mmHg)a

81.75 ± 12.8

83.45 ± 20.0

LDL-C (µmol/l)a

3.5 ± 1.6

3.5 ± 1.7

HDL-C (µmol/l)a

1.18 ± 0.46

1.15 ± 0.35

Troponin-I (pg/ml)a

13.1 ± 9.4

24.9 ± 20.0

Red cell distribution width (%)a

14.9 ± 3.2

16.0 ± 3.3

Glycated hemoglobin A1Ca

5.7 ± 1.8

6.9 ± 1.7

Brain natriuretic peptide (pg/ml)a

50.3 ± 38.0

176.2 ± 98.9

Ejection fraction (%)a

61.5 ± 6.4

51.9 ± 6.4

Coronary flow reservea

1.67 ± 0.28

2.42 ± 0.51

  1. NYHA New York Heart Association, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol
  2. aData are expressed as mean ± standard deviation